F.D.A. Advisory Panel Opposes Curb on Anemia Drugs
414338
The vote by the panel advising the Food and Drug Administration was a a rare reprieve to Amgen, the manufacturer of the drugs.
603694
TORONTO -- Ontario Health Minister George Smitherman denied yesterday that the province is trying to bribe doctors into cutting prescription drug costs to the poor and elderly, saying the proposal is meant to curb the over-prescription of medication to
398593
U.S. regulators on Friday turned  down AstraZeneca Plc's  AZN.L AZN.N anti-clotting drug  Exanta, following the advice of an advisory panel on which some  members had voiced doubt about the drug's safety and  effectiveness.
14666
A US advisory panel on Friday recommended against approving AstraZeneca&#39;s new stroke prevention medication, Exanta, citing concerns about the drug&#39;s effect on the liver.
157454
U.S. health regulators recommended  on Thursday that doctors limit prescribing painkillers like  Pfizer Inc.'s Celebrex and Bextra, in light of recent evidence  that they may increase the risk of heart attack and stroke.
370275
BETHESDA, Md.  - A U.S. advisory panel on Friday  urged regulators to reject over-the-counter sales of Merck &  Co. Inc.'s cholesterol-lowering drug Mevacor because of doubts  the medicine could be used safely without a doctor's guidance.
108049
WASHINGTON -- The Food and Drug Administration warned consumers yesterday not to buy or use the supplements Actra-Rx or Yilishen because they contain an ingredient that could lower blood pressure to unsafe levels.
543431
Drugs that treat anemia caused by kidney failure provide important benefits despite the risks for some patients at high doses, Amgen Inc. told a U.S. advisory panel on Tuesday.
115232
SILVER SPRING, Maryland  - U.S. regulators should reject a proposed weight-loss pill called Zimulti because of concerns it may increase suicidal thinking and depression, an advisory panel unanimously said on Wednesday.
450325
U.S. health officials and drugmaker GlaxoSmithKline Plc are likely to face tough questioning from lawmakers on Wednesday over their handling of data suggesting a heart risk with the widely used diabetes pill Avandia.
558052
An advisory panel recommends approval of a new HIV drug that blocks one key element.
678814
Anemia drugs sold by Amgen Inc. and Johnson & Johnson will carry a new boxed warning advising doctors to choose the lowest dose needed to avoid blood transfusions, the U.S. Food and Drug Administration said on Friday.
430832
WASHINGTON  New warnings on anemia drugs  Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.
145690
A senior Medicare official said the  case for cutting the use of controversial anemia drugs sold by  Amgen Inc and Johnson & Johnson has become stronger since the  agency decided last year to cut payments for their use in  cancer patients.
196813
U.S. health officials on Thursday  called on doctors to limit prescribing Pfizer Inc. painkillers  Celebrex and Bextra in light of recent evidence that they may  increase the risk of heart attack and stroke.
468296
Doctors in the United States have shunned GlaxoSmithKline Plc's diabetes drug Avandia since a study was published last week linking the drug to heart-attack risk, according to daily prescription data.
186518
A proposed leukemia drug should not receive federal approval, government advisers recommended Wednesday.